AAIC 2025 Abstract
Biomarkers for Alzheimer's disease to differentiate Normal, SCD, and MCI subjects and their correlation with cognitive dysfunction
Study in peopleBiomarkers
Abstract
Background: Plasma has been used extensively to identify novel plasma biomarkers. We assessed the potential of several plasma biomarkers for differential diagnosis of early stages of Alzheimer's disease (AD). Method: We enrolled 310 patients at the NYU Alzheimer's Disease Research Center.
